Shree Ganesh Bio-Tech (India) informs about disclosure

25 Jun 2021 Evaluate

Pursuant to SEBI Circular-CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding statement on Deviation or variation for proceeds of public issue/ Rights Issue/ preferential issue, Qualified institutional placement (QIP) etc., read with Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Shree Ganesh Bio-Tech (India) has informed that the Company does not have any funds remaining unutilised as on 31st March 2021, or as on date, out of the proceeds of public issue/ Rights Issue/ preferential issue, qualified institutional placement (QIP) etc., if any undertaken by it at any time in the past. In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the said Regulation/ Circular.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh BioTech Share Price

0.64 -0.01 (-1.54%)
29-Jan-2026 09:54 View Price Chart
Peers
Company Name CMP
Venkys India 1498.75
Mangalam Global Ent 12.21
Kaveri Seed 864.30
Regaal Resources 60.69
Simran Farms 167.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×